Literature DB >> 3339926

Hyperlipidemia in association with childhood sensorineural hearing loss.

M Strome1, P Topf, D M Vernick.   

Abstract

In adults there has been an association noted between hyperlipidemia and sensorineural hearing loss. Etiologic considerations include hyperviscosity of the serum, vascular occlusion and an increased susceptibility to noise. Until now this correlation, to our knowledge, has not been made in the pediatric population. Several children with bilateral fluctuating sensorineural hearing losses have been identified with hyperlipidemia. The fluctuations in hearing varied with lipid levels. With dietary controls, the cholesterol levels returned to what would be near the norm for the pediatric population and hearing returned to near baseline. Unexplained fluctuating sensorineural hearing losses in children warrant the consideration of hyperlipidemia. Discovering a potentially reversible etiology for hearing loss is significant but more importantly, may lead to the early detection of hyperlipidemia in the young patient.

Entities:  

Mesh:

Year:  1988        PMID: 3339926     DOI: 10.1288/00005537-198802000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss.

Authors:  D Ullrich; G Aurbach; C Drobik
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Dyslipidemia and auditory function.

Authors:  M Bradley Evans; Ross Tonini; Cynthia Do Shope; John S Oghalai; James F Jerger; William Insull; William E Brownell
Journal:  Otol Neurotol       Date:  2006-08       Impact factor: 2.311

3.  Simvastatin Results in a Dose-Dependent Toxic Effect on Spiral Ganglion Neurons in an In Vitro Organotypic Culture Assay.

Authors:  Katharina Leitmeyer; Andrea Glutz; Cristian Setz; Leonie Wieland; Sulamith Egloff; Daniel Bodmer; Yves Brand
Journal:  Biomed Res Int       Date:  2016-03-14       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.